Display options
Share it on

Clin Ophthalmol. 2015 Aug 13;9:1457-61. doi: 10.2147/OPTH.S81262. eCollection 2015.

Portable single port 23-gauge vitrectomy in postoperative endophthalmitis.

Clinical ophthalmology (Auckland, N.Z.)

Fabian Höhn, Florian Ta Kretz, Saumil Sheth, S Natarajan, Pankaj Singh, Frank H Koch, Michael J Koss

Affiliations

  1. Helios Klinikum Pforzheim, Pforzheim, Germany.
  2. Department of Ophthalmology, Hospital of the Ruprecht-Karls University, Heidelberg, Germany.
  3. Aditya Jyot Eye Hospital Pvt. Ltd, Mumbai, India.
  4. Department of Ophthalmology, Hospital of the Goethe University, Frankfurt am Main, Germany.
  5. Department of Ophthalmology, Hospital of the Ruprecht-Karls University, Heidelberg, Germany ; Department of Ophthalmology, University of Southern California, Los Angeles, CA, USA.

PMID: 26316685 PMCID: PMC4540141 DOI: 10.2147/OPTH.S81262

Abstract

AIM: To evaluate the safety and effectiveness of the Intrector(®) for treating postoperative endophthalmitis.

MATERIALS AND METHODS: In a retrospective multicenter study, patients who received a single port 23-gauge core pars plana vitrectomy and isovolumetric injection of vancomycin, ceftazidime, and dexamethasone/amphotericin B using the Intrector(®) for postoperative endophthalmitis of intermediate severity (grade II or III vitreous inflammation and best-corrected visual acuity between hand movements and 0.3 logMAR [logarithm of the minimum angle of resolution]) were evaluated. Improvement in visual acuity, resolution of intraocular inflammation, the need for additional surgical procedures, and the development of complications were evaluated at a 1-month follow-up examination.

RESULTS: Fifteen patients (mean age 55.6±7.2 years) underwent treatment with the Intrector(®). The mean vitreous volume aspirated was 0.78±0.22 mL. The vitreous samples indicated positive microorganism culture results in six of the 15 cases, but the samples were positive when analyzed by real-time polymerase chain reaction in all cases (15/15). The mean best-corrected visual acuity improved significantly (P=0.01) from 0.88±0.29 (logMAR) to 0.32±0.28. Each patient demonstrated at least three lines of visual improvement. No additional medical or surgical interventions were required, and the complete resolution of intraocular inflammation was noted in all patients at the 1-month follow-up examination. No procedure-related complications were observed.

CONCLUSION: The Intrector(®) may be a safe and effective treatment option for infectious postoperative endophthalmitis. Larger studies comparing the outcomes of the Intrector(®) to the traditional treatments for postoperative endophthalmitis need to be conducted before its role in the treatment of postoperative endophthalmitis can be properly defined.

Keywords: 23-gauge vitrectomy; Intrector®; postoperative endophthalmitis

References

  1. J Refract Surg. 1997 Jul-Aug;13(4):388-91 - PubMed
  2. Ophthalmology. 1995 Mar;102(3):382-7 - PubMed
  3. Arch Ophthalmol. 2011 Dec;129(12):1599-604 - PubMed
  4. Am J Ophthalmol. 2005 Sep;140(3):509-16 - PubMed
  5. Indian J Ophthalmol. 2003 Jun;51(2):139-45 - PubMed
  6. Am J Ophthalmol. 2006 Jun;141(6):1022-1026 - PubMed
  7. Ophthalmologica. 2010;224(2):72-8 - PubMed
  8. Am J Ophthalmol. 1996 Jul;122(1):1-17 - PubMed
  9. Arch Ophthalmol. 1995 Dec;113(12):1479-96 - PubMed
  10. Retin Cases Brief Rep. 2008 Fall;2(4):264-5 - PubMed
  11. Am J Ophthalmol. 1982 Jul;94(1):91-6 - PubMed
  12. J Pediatr Orthop. 2013 Apr-May;33(3):e28-33 - PubMed
  13. Retina. 2002 Dec;22(6):725-32 - PubMed
  14. Mol Diagn Ther. 2006;10(5):319-26 - PubMed
  15. Curr Opin Rheumatol. 2008 Jul;20(4):463-70 - PubMed

Publication Types